Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.

Ariza MJ, Rioja J, Ibarretxe D, Camacho A, Díaz-Díaz JL, Mangas A, Carbayo-Herencia JA, Ruiz-Ocaña P, Lamíquiz-Moneo I, Mosquera D, Sáenz P, Masana L, Muñiz-Grijalvo O, Pérez-Calahorra S, Valdivielso P; Spanish Dyslipidemia Registry.

J Clin Lipidol. 2018 Aug 1. pii: S1933-2874(18)30353-2. doi: 10.1016/j.jacl.2018.07.013. [Epub ahead of print]

PMID:
30150141
2.

Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial.

Mateo-Gallego R, Lacalle L, Pérez-Calahorra S, Marco-Benedí V, Recasens V, Padrón N, Lamiquiz-Moneo I, Baila-Rueda L, Jarauta E, Calmarza P, Cenarro A, Civeira F.

J Clin Lipidol. 2018 Sep - Oct;12(5):1190-1198. doi: 10.1016/j.jacl.2018.06.017. Epub 2018 Jul 4.

PMID:
30049591
3.

Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia.

Baila-Rueda L, Lamiquiz-Moneo I, Jarauta E, Mateo-Gallego R, Perez-Calahorra S, Marco-Benedí V, Bea AM, Cenarro A, Civeira F.

J Transl Med. 2018 Jan 15;16(1):6. doi: 10.1186/s12967-018-1380-3.

4.

Different protein composition of low-calorie diet differently impacts adipokine profile irrespective of weight loss in overweight and obese women.

Mateo-Gallego R, Lamiquiz-Moneo I, Perez-Calahorra S, Marco-Benedí V, Bea AM, Baila-Rueda L, Laclaustra M, Peñalvo JL, Civeira F, Cenarro A.

Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):133-142. doi: 10.1016/j.numecd.2017.10.024. Epub 2017 Nov 4.

PMID:
29329923
5.

Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.

Baila-Rueda L, Cenarro A, Lamiquiz-Moneo I, Perez-Calahorra S, Bea AM, Marco-Benedí V, Jarauta E, Mateo-Gallego R, Civeira F.

J Nutr Biochem. 2018 Mar;53:48-57. doi: 10.1016/j.jnutbio.2017.10.005. Epub 2017 Nov 27.

PMID:
29190549
6.

National Dyslipidemia Registry of the Spanish Arteriosclerosis Society: Current status.

Pérez-Calahorra S, Sánchez-Hernández RM, Plana N, Valdivielso P, Civeira F.

Clin Investig Arterioscler. 2017 Nov - Dec;29(6):248-253. doi: 10.1016/j.arteri.2017.09.001. Epub 2017 Nov 2. English, Spanish.

PMID:
29102473
7.

ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols.

Lamiquiz-Moneo I, Baila-Rueda L, Bea AM, Mateo-Gallego R, Pérez-Calahorra S, Marco-Benedí V, Martín-Navarro A, Ros E, Cofán M, Rodríguez-Rey JC, Pocovi M, Cenarro A, Civeira F.

J Clin Lipidol. 2017 Nov - Dec;11(6):1432-1440.e4. doi: 10.1016/j.jacl.2017.09.005. Epub 2017 Oct 4.

PMID:
29066094
8.

Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.

Lamiquiz-Moneo I, Pérez-Ruiz MR, Jarauta E, Tejedor MT, Bea AM, Mateo-Gallego R, Pérez-Calahorra S, Baila-Rueda L, Marco-Benedí V, de Castro-Orós I, Cenarro A, Civeira F.

Rev Esp Cardiol (Engl Ed). 2018 May;71(5):351-356. doi: 10.1016/j.rec.2017.07.010. Epub 2017 Sep 14. English, Spanish.

PMID:
28919240
9.

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia.

Climent E, Pérez-Calahorra S, Marco-Benedí V, Plana N, Sánchez R, Ros E, Ascaso JF, Puzo J, Almagro F, Lahoz C, Civeira F, Pedro-Botet J.

Sci Rep. 2017 Jul 17;7(1):5596. doi: 10.1038/s41598-017-06101-6.

10.

Effect of intensive LDL cholesterol lowering with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia.

Bea AM, Perez-Calahorra S, Marco-Benedi V, Lamiquiz-Moneo I, Jarauta E, Mateo-Gallego R, Civeira F.

Atherosclerosis. 2017 Aug;263:92-96. doi: 10.1016/j.atherosclerosis.2017.06.009. Epub 2017 Jun 8.

PMID:
28623742
11.

How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?

Masana L, Plana N, Pérez-Calahorra S, Ibarretxe D, Lamiquiz-Moneo I, Pedro-Botet J, Suárez-Tembra M, Valdivielso P, Ortega E, Civeira F; Dyslipidemia Registry of the Spanish Arteriosclerosis Society.

Atherosclerosis. 2017 Jul;262:107-112. doi: 10.1016/j.atherosclerosis.2017.05.013. Epub 2017 May 12.

PMID:
28531826
12.

Association Between the Presence of Carotid Artery Plaque and Cardiovascular Events in Patients With Genetic Hypercholesterolemia.

Bea AM, Civeira F, Jarauta E, Lamiquiz-Moneo I, Pérez-Calahorra S, Marco-Benedí V, Cenarro A, Mateo-Gallego R.

Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):551-558. doi: 10.1016/j.rec.2017.01.023. Epub 2017 Feb 17. English, Spanish.

PMID:
28215923
13.

Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.

Pérez-Calahorra S, Sánchez-Hernández RM, Plana N, Marco-Benedi V, Pedro-Botet J, Almagro F, Brea A, Ascaso JF, Lahoz C, Civeira F; Dyslipidemia Registry of Spanish Arteriosclerosis Society.

Am J Cardiol. 2017 Mar 1;119(5):742-748. doi: 10.1016/j.amjcard.2016.11.025. Epub 2016 Dec 2.

PMID:
28081939
14.

Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.

Jarauta E, Pérez-Ruiz MR, Pérez-Calahorra S, Mateo-Gallego R, Cenarro A, Cofán M, Ros E, Civeira F, Tejedor MT.

J Clin Lipidol. 2016 Nov - Dec;10(6):1397-1405.e2. doi: 10.1016/j.jacl.2016.09.011. Epub 2016 Sep 22.

PMID:
27919357
15.

Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.

Sánchez-Hernández RM, Civeira F, Stef M, Perez-Calahorra S, Almagro F, Plana N, Novoa FJ, Sáenz-Aranzubía P, Mosquera D, Soler C, Fuentes FJ, Brito-Casillas Y, Real JT, Blanco-Vaca F, Ascaso JF, Pocovi M.

Circ Cardiovasc Genet. 2016 Dec;9(6):504-510. doi: 10.1161/CIRCGENETICS.116.001545. Epub 2016 Oct 26.

PMID:
27784735
16.

Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis.

Baila-Rueda L, Cenarro A, Lamiquiz-Moneo I, Mateo-Gallego R, Bea AM, Perez-Calahorra S, Marco-Benedi V, Civeira F.

J Steroid Biochem Mol Biol. 2017 May;169:226-233. doi: 10.1016/j.jsbmb.2016.10.003. Epub 2016 Oct 18.

PMID:
27769814
17.

Rapid resolution of xanthelasmas after treatment with alirocumab.

Civeira F, Perez-Calahorra S, Mateo-Gallego R.

J Clin Lipidol. 2016 Sep-Oct;10(5):1259-61. doi: 10.1016/j.jacl.2016.07.007. Epub 2016 Aug 2.

PMID:
27678444
18.

Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain.

Lamiquiz-Moneo I, Blanco-Torrecilla C, Bea AM, Mateo-Gallego R, Pérez-Calahorra S, Baila-Rueda L, Cenarro A, Civeira F, de Castro-Orós I.

Lipids Health Dis. 2016 Apr 23;15:82. doi: 10.1186/s12944-016-0251-2.

19.

Energy-restricted, high-protein diets more effectively impact cardiometabolic profile in overweight and obese women than lower-protein diets.

Mateo-Gallego R, Marco-Benedí V, Perez-Calahorra S, Bea AM, Baila-Rueda L, Lamiquiz-Moneo I, de Castro-Orós I, Cenarro A, Civeira F.

Clin Nutr. 2017 Apr;36(2):371-379. doi: 10.1016/j.clnu.2016.01.018. Epub 2016 Jan 29.

PMID:
26875447
20.

Effect of different fat-enriched meats on non-cholesterol sterols and oxysterols as markers of cholesterol metabolism: Results of a randomized and cross-over clinical trial.

Baila-Rueda L, Mateo-Gallego R, Pérez-Calahorra S, Lamiquiz-Moneo I, de Castro-Orós I, Cenarro A, Civeira F.

Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):853-9. doi: 10.1016/j.numecd.2015.06.008. Epub 2015 Jun 23.

PMID:
26232911

Supplemental Content

Loading ...
Support Center